Similar Articles
531 Hepatocellular carcinoma biomarkers, an imminent need
532 Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
533 Artificial neural network for prediction of acute kidney injury after liver transplantation for cirrhosis and hepatocellular carcinoma
534 Hepatocellular carcinoma risk after viral response in hepatitis C virus-advanced fibrosis: Who to screen and for how long?
535 Long-term survival outcome of laparoscopic liver resection for hepatocellular carcinoma
536 Research progress regarding programmed cell death 1/programmed cell death ligand 1 inhibitors combined with targeted therapy for treating hepatocellular carcinoma
537 Outcomes of reduction hepatectomy combined with postoperative multidisciplinary therapy for advanced hepatocellular carcinoma
538 Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study
539 Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
540 Surveillance for hepatocellular carcinoma at the community level: Easier said than done
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA